Evidence map›Paper›PMID 32061038›Full record

ArticleNeurogastroenterology and motility2020

Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: Relationship with etiology, gastric emptying, and symptom severity.

Linda Nguyen, Laura A Wilson, Laura Miriel, Pankaj J Pasricha, Braden Kuo, William L Hasler, Richard W McCallum, Irene Sarosiek, Kenneth L Koch, William J Snape and 8 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Neurogastroenterology and motility, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05846802 recruitingnot on this mapstarted 2024, after this paper: background citation

Gastroparesis Registry 4 (GpR4): Improving the Understanding of Gastroparesis and Functional Dyspepsia

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan2024 to 2027Enrolled250ConditionsGastroparesis, Gastroparesis Nondiabetic, Gastroparesis Due to Diabetes Mellitus Type I, Gastroparesis Due to Diabetes Mellitus Type II
NCT06606782 completednot on this map

Evaluation of Incidence of Stomach Fullness in Elective Surgical Patients and Investigation of Associated Factors: Prospective Observational Study

TypeobservationalSponsorRecep Tayyip Erdogan UniversityRan2020 to 2022Enrolled404ConditionsGastric Emptying, Preoperative Care, Preoperative Fasting, Elective Surgical Procedures
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Endocannabinoid signaling in stress, nausea, and vomiting.Neurogastroenterology and motility · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Postoperative delayed gastric emptying: may gut microbiota play a role?Frontiers in cellular and infection microbiology · 2024
    Review
  19. Article
  20. The Gut-brain Connection and Episodic Migraine: an Update.Current pain and headache reports · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 1 country.

Linda NguyenStanford University, Palo Alto, California.ORCID 0000-0002-3498-6897
Laura A WilsonJohns Hopkins University, Baltimore, Maryland.
Laura MirielJohns Hopkins University, Baltimore, Maryland.
Pankaj J PasrichaJohns Hopkins University, Baltimore, Maryland.
Braden KuoHarvard University, Boston, Massachusetts.ORCID 0000-0002-7228-7317
William L HaslerUniversity of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-6158-2871
Richard W McCallumTexas Tech University, El Paso, Texas.ORCID 0000-0002-6652-8049
Irene SarosiekTexas Tech University, El Paso, Texas.
Kenneth L KochWake Forest University, Winston-Salem, North Carolina.
William J SnapeCalifornia Pacific Medical Center, San Francisco, California.
Gianrico FarrugiaMayo Clinic, Rochester, Minnesota.
Madhusudan GroverMayo Clinic, Rochester, Minnesota.ORCID 0000-0001-5092-0831
John ClarkeStanford University, Palo Alto, California.
Henry P ParkmanTemple University, Philadelphia, Pennsylvania.ORCID 0000-0003-4904-4891
James TonasciaJohns Hopkins University, Baltimore, Maryland.
Frank HamiltonNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Thomas L AbellUniversity of Louisville, Louisville, Kentucky.ORCID 0000-0002-3175-5161
NIDDK Gastroparesis Clinical Research Consortium (GpCRC)
Johns Hopkins University · USMayo Clinic · USPalo Alto University · USTexas Tech University · USCalifornia Pacific Medical Center · USHarvard University Press · USNational Institute of Diabetes and Digestive and Kidney Diseases · USTemple University · USUniversity of Louisville · USUniversity of Michigan · USWake Forest University · US

Funding

Gastroparesis Consortium Continuation-Data Coordinating CenterU01DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 2006 to 2015
$17.4M
PGpR2 Year 4 Supplement for the Scientific Data Research Center (SDRC) of the GpCRC 4U24DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI David M Shade · 2017 to 2026
$11.7M
Subtypes of GastroparesisU01DK073974 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Baharak Moshiree · 2006 to 2026
$7.4M
Temple University Gastroparesis Clinical CenterU01DK073975 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI HENRY PAUL PARKMAN · 2006 to 2026
$7.4M
U of L Clinical Center to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis ConsortiumU01DK074007 · NIDDK · UNIVERSITY OF MISSISSIPPI MED CTR · PI Thomas Lyman Abell · 2006 to 2026
$7.0M
Molecular Approaches to Pathogenesis/Therapy in GastropaU01DK073983 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PANKAJ J PASRICHA · 2006 to 2026
$6.8M
New England Gastropareis Consortium: Neurobiology of GastroparesisU01DK112193 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Helen Burton Murray, Braden Kuo · 2016 to 2026
$4.8M
Visceral Afferent Dysfunction in Diabetic GastropathyU01DK073985 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HASLER, WILLIAM L · 2006 to 2015
$2.7M
NIDDK NIH HHS Grant # U01DK073983, U01DK073975, U01DK073985, U01NIDDK NIH HHS U01 DK073974NIDDK NIH HHS U01 DK073975NIDDK NIH HHS U01 DK073983NIDDK NIH HHS U01 DK073985NIDDK NIH HHS U01 DK074007NIDDK NIH HHS U01 DK074008NIDDK NIH HHS U01 DK112193NIDDK NIH HHS U24 DK074008
6 · The paper itself

Abstract

backgroundAutonomic dysfunction can be present in patients with idiopathic and diabetic gastroparesis. The role of autonomic dysfunction relating to gastric emptying and upper gastrointestinal symptoms in patients with gastroparesis and chronic unexplained nausea and vomiting (CUNV) remains unclear. The aim of our study is to evaluate autonomic function in patients with gastroparesis and CUNV with respect to etiology, gastric emptying and symptom severity.

methodsWe studied 242 patients with chronic gastroparetic symptoms recruited at eight centers. All patients had a gastric emptying scintigraphy within 6 months of the study. Symptom severity was assessed using the gastroparesis cardinal symptom index. Autonomic function testing was performed at baseline enrollment using the ANX 3.0 autonomic monitoring system which measures heart rate variability and respiratory activity measurements. KEY

resultsLow sympathetic response to challenge (Valsalva or standing) was the most common abnormality seen impacting 89% diabetic and 74% idiopathic patients. Diabetics compared to idiopathics, exhibited greater global hypofunction with sympathetic (OR = 4.7, 95% CI 2.2-10.3; P < .001) and parasympathetic (OR = 7.2, 95% CI 3.4-15.0; P < .001) dysfunction. Patients with delayed gastric emptying were more likely to have paradoxic parasympathetic excessive during sympathetic challenge [(Valsalva or standing) 40% vs. 26%, P = .05]. Patients with more severe symptoms exhibited greater parasympathetic dysfunction compared to those with mild-moderate symptoms: resting sympathovagal balance [LFa/RFa 1.8 (1.0-3.1) vs. 1.2 (0.6-2.3), P = .006)] and standing parasympathetic activity [0.4 (0.1-0.8) vs. 0.6 (0.2-1.7); P = .03].

conclusionsAutonomic dysfunction was common in patients with gastroparesis and CUNV. Parasympathetic dysfunction was associated with delayed gastric emptying and more severe upper gastrointestinal symptoms. Conversely, sympathetic hypofunction was associated with milder symptoms. INFERENCES: Gastroparesis and CUNV may be a manifestation of GI autonomic dysfunction or imbalance, such that sympathetic dysfunction occurs early on in the manifestation of chronic upper GI symptoms, while parasympathetic dysfunction results in more severe symptoms and delayed gastric emptying.

Indexed as

AdultAutonomic Nervous SystemFemaleGastric EmptyingGastroparesisHumansMaleMiddle AgedNauseaSeverity of Illness IndexVomitingautonomic functiondysautonomiagastric emptyinggastroparesisheart rate variability

Identifiers

PMID32061038
PMCPMC7377964
OpenAlexW3005984323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.